Research programme: Japanese encephalitis vaccine - Sinovac BiotechAlternative Names: Inactivated JEV vaccine - Sinovac Biotech
Latest Information Update: 04 Jun 2009
At a glance
- Originator Sinovac Biotech
- Class Viral vaccines
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Preclinical Encephalitis virus infections
Most Recent Events
- 18 Sep 2008 Preclinical development is ongoing in China
- 18 Jul 2006 Preclinical trials in Encephalitis virus infections in China (Parenteral)